To investigate possible consequences of reduced CDK5 activation on Tau pathology, we co-transfected neuroblastoma cells with eGFP-tagged Tau[R406W] mutant along with either WT 5-HT7R or phenylalanine mutants, followed by the analysis of Tau phosphorylation and aggregation. The gene discussed is CDK5; the disease is neuroblastoma.